Quality Standards & Testing - Cellugenix Peptides

Cellugenix Peptides follows a structured production and testing process for every batch manufactured, from raw material sourcing through final Certificate of Analysis (COA) generation. All products are intended strictly for laboratory research use and are not approved for human or animal consumption, injection, or any clinical application. This page explains how peptides are synthesized, tested, and verified before they reach a researcher's bench.

Peptide Synthesis Process

Cellugenix peptides are produced using solid-phase peptide synthesis (SPPS), the standard method used across the research peptide industry for building peptide chains with precision. The process happens in a sequence of controlled steps:

01

Raw material sourcing – Amino acid building blocks and reagents are sourced from qualified suppliers and checked for identity before use.

02

Resin attachment – The first amino acid is attached to a solid resin support, which anchors the growing peptide chain during synthesis.

03

Sequential coupling – Amino acids are added one at a time in the correct order, following the target peptide sequence, with each addition monitored for completion before the next step begins.

04

Deprotection cycles – Protective chemical groups are removed between coupling steps so the next amino acid can attach at the right position.

05

Cleavage from resin – Once the full sequence is built, the completed peptide chain is cleaved from the solid resin support.

06

Purification – The raw peptide is purified using preparative HPLC to separate the target peptide from any incomplete sequences or byproducts formed during synthesis.

07

Lyophilization – The purified peptide is freeze-dried into a stable powder form for shipping and storage.

Testing Methods

Every batch produced by Cellugenix goes through a defined testing sequence before it is approved for sale. Testing is handled by Testides, an independent third-party laboratory, so results are not generated in-house.

Test Purpose Method Used
Purity analysis Confirms the percentage of target peptide in the sample Reversed-phase HPLC (High-Performance Liquid Chromatography)
Identity confirmation Confirms the molecular structure matches the intended peptide Mass spectrometry (MS), comparing observed mass to theoretical mass
Endotoxin testing Checks for bacterial contamination byproducts Endotoxin quantification assay
Residual solvent testing Checks for leftover solvents from the synthesis process Solvent analysis
Appearance and solubility check Confirms physical characteristics match expected standards Visual inspection and solubility testing

What Each Certificate of Analysis (COA) Contains

Every batch shipped by Cellugenix is accompanied by a COA generated by Testides. Each COA includes the following information:

  • Peptide name and sequence
  • Molecular formula and molecular weight
  • Batch/lot number, matching the number printed on the physical vial
  • Production date and, where applicable, expiry date
  • HPLC purity percentage, along with the chromatogram
  • Mass spectrometry results, showing observed versus theoretical mass
  • Endotoxin levels
  • Residual solvent levels
  • Physical appearance notes (color, form)
  • Name of the testing laboratory (Testides)

Updated COAs for current batches can be viewed directly on the Cellugenix website. Researchers are encouraged to match the lot number on their vial with the lot number listed on the corresponding COA before beginning any work with the sample.

Purity Standards

Cellugenix sets a minimum purity threshold for every peptide it sells, and batches that fall below this threshold are not released for sale.

Purity Grade Minimum HPLC Purity Typical Use Case
Standard research grade 98% General laboratory research
High-purity grade 99%+ Studies requiring tighter analytical precision

Batch Consistency and Record-Keeping

We prioritize transparency and traceability for every product we manufacture. This section details how we track, archive, and manage batch data to ensure reliable results for your research.

  • Each production batch is assigned a unique lot number at the time of manufacturing.
  • Testing results are recorded and archived against the corresponding lot number for future reference.
  • If a batch does not meet the purity or identity standards set by Cellugenix, it is not released for sale, and the batch is documented internally as a failed batch.
  • Researchers can request historical COA data for previously purchased lot numbers by contacting Cellugenix support.

Quality Assurance Checklist (Internal Process)

Our internal quality control process ensures that every batch meets our standards before it is made available. This checklist outlines the steps we follow, from raw material verification to final public release.

  1. Raw materials checked for identity before synthesis

  2. Synthesis monitored at each coupling and deprotection step

  3. Purification performed via preparative HPLC

  4. Batch sent to Testides for independent third-party testing

  5. Purity, identity, endotoxin, and residual solvent results reviewed against minimum standards

  6. COA generated and matched to lot number

  7. COA published on the Cellugenix website for researcher reference

  8. Batch released for sale only after all thresholds are met

Important Reminder

All quality and purity data published by Cellugenix describes the characteristics of a research reagent and does not indicate suitability, safety, or approval for human or animal use of any kind.

Products remain intended strictly for laboratory research by qualified researchers, in accordance with applicable laws and institutional protocols.

0